Table 1.
Characteristics of Patients Discontinued Opioid (n = 25)
| Characteristic | Nonwithdrawal syndrome cases (n = 22) | Withdrawal syndrome cases (n = 3) |
|---|---|---|
| Age (years) | 63.7 ± 16.4 | 45.0 ± 3.5 |
| Male gender (%) | 40.9 | 33.3 |
| Cancer diagnosis | ||
| Gynecological | 5 | 2 |
| Head and neck | 5 | 0 |
| Lymphoma | 4 | 0 |
| Genitourinary | 3 | 0 |
| Breast | 2 | 0 |
| Leukemia | 1 | 0 |
| Lung | 1 | 0 |
| Melanoma | 1 | 0 |
| Liver | 0 | 1 |
| Pain causes | ||
| Pain related to cancer | 14 | 0 |
| Pain related to treatment | 6 | 2 |
| Pain unrelated to cancer/treatment | 2 | 1 |
| Opioids | ||
| Fentanyl | 14 | 1 |
| Oxycodone | 6 | 2 |
| Morphine | 1 | 0 |
| Tapentadol | 1 | 0 |
| Route of opioid administration | ||
| Transdermal | 13 | 0 |
| Oral | 5 | 1 |
| Continuous intravenous infusion | 4 | 2 |
| Maximum dose of opioid | ||
| (Oral morphine equivalent: mg/day) | 55.7 ± 43.6 | 352.0 ± 194.0 |
| Duration of opioid administration (days) | 29.0 ± 34.5 | 82.0 ± 108.9 |